Immunization financing

In accordance with past trends, immunization spending continues to rise. Recent research shows that routine immunization spending in Gavi-eligible countries reached US$27 per fully immunized child around the beginning of the decade and has been projected to rise to $45 per fully immunized child by 2016. The introduction of new, more expensive vaccines is contributing to this increase. The prospect and need for additional domestic financing for immunization programs and the broader health system is receiving attention. A number of countries are now approaching the thresholds for graduation of support from Gavi, the Vaccine Alliance, leading to discussions of how to best prepare for self-sufficiency. Gavi’s new transition process includes four phases as countries move toward the fully self-financing phase. Meanwhile, donors continue to show strong support for immunization. For instance, Gavi’s January 2015 pledging conference raised more than $7.5 billion for the 2016 to 2020 period. In spite of these successes, income growth and access to immunization services are not uniformly distributed across the world or within countries. Equitable coverage and reaching the poorest will remain challenges to be confronted in the coming years. As a result, immunization financing is a critical tool for providing access to lifesaving vaccines to those who need them most. Visit PATH’s website to learn more about its work to facilitate vaccine affordability and availability in low-resource countries.

View resources on immunization financing

Page last updated: July 2017.

Photo: PATH/Amy MacIver.